These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29906006)

  • 41. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
    Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorouracil cream 0.5% for actinic keratoses on multiple body sites: an 18-month open-label study.
    Stough D; Bucko AD; Vamvakias G; Rafal ES; Davis SA
    Cutis; 2010 May; 85(5):267-73. PubMed ID: 20540418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefit of uridine triacetate (Vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency.
    Saif MW; Diasio RB
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):151-6. PubMed ID: 27278667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal melanonychia induced by capecitabine.
    Paravar T; Hymes SR
    Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study.
    Ondo AL; Padilla RS; Miedler JD; Cockerell CJ; Kerner JD; Steiner RL; Mings SM; Shanler SD
    Dermatol Surg; 2012 Sep; 38(9):1469-76. PubMed ID: 22712515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
    Kaur RR; Alikhan A; Maibach HI
    J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.
    Johnson MR; Hageboutros A; Wang K; High L; Smith JB; Diasio RB
    Clin Cancer Res; 1999 Aug; 5(8):2006-11. PubMed ID: 10473079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized and controlled pilot study of the pragmatic use of mobile phone based follow up of actinic keratoses treated with topical 5-fluorouracil.
    Bosanac SS; Nguyen V; Bui D; Eisen DB; Sivamani RK
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Temporary ectropion due to topical fluorouracil.
    Hecker D; Hacker SM; Ramos-Caro FA; Flowers FP
    Cutis; 1994 Mar; 53(3):137-8. PubMed ID: 8187543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Japanese Patient with Gastric Cancer and Dihydropyrimidine Dehydrogenase Deficiency Presenting with DPYD Variants.
    Ishiguro M; Takenaka R; Ogura K; Hiratsuka A; Takeda H; Kawai D; Tsugeno H; Fujiki S; Okada H
    Acta Med Okayama; 2020 Dec; 74(6):557-562. PubMed ID: 33361878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early-Onset 5-Fluorouracil Toxicity in a Patient Negative for Dihydropyrimidine Dehydrogenase Mutations: The Clinical Course of Reversal with Uridine Triacetate.
    Vaudo CE; Gil B; Galuski K; Zarwan C; Nugent FW
    Pharmacotherapy; 2016 Nov; 36(11):e178-e182. PubMed ID: 27716991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
    Tallon B; Turnbull N
    Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of actinic keratoses with topical fluorouracil.
    West DA; Aires DJ
    Am Fam Physician; 2010 May; 81(10):1186. PubMed ID: 20507040
    [No Abstract]   [Full Text] [Related]  

  • 54. 5-Fluorouracil for Actinic Keratosis Treatment and Chemoprevention: A Randomized Controlled Trial.
    Walker JL; Siegel JA; Sachar M; Pomerantz H; Chen SC; Swetter SM; Dellavalle RP; Stricklin GP; Qureshi AA; DiGiovanna JJ; Weinstock MA
    J Invest Dermatol; 2017 Jun; 137(6):1367-1370. PubMed ID: 28532759
    [No Abstract]   [Full Text] [Related]  

  • 55. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dihydropyrimidine dehydrogenase deficiency: a potential etiology for 5-fluorouracil-induced neurotoxicity.
    Risso ME; Hasson NK; Lum BL
    Pharmacotherapy; 1997; 17(4):847-8; discussion 849. PubMed ID: 9250572
    [No Abstract]   [Full Text] [Related]  

  • 57. Eczema herpeticum complicating topical 5-Fluorouracil therapy.
    Levesque SW; Hantash BM
    Dermatitis; 2012; 23(5):240-1. PubMed ID: 23010835
    [No Abstract]   [Full Text] [Related]  

  • 58. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.
    van Kuilenburg AB
    Eur J Cancer; 2004 May; 40(7):939-50. PubMed ID: 15093568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.